www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

chinadaily.com.cn
left corner left corner
China Daily Website

Fosun Pharma to launch HK IPO

Updated: 2012-10-17 10:52
By Sophie He ( China Daily)

Fosun Pharma to launch HK IPO

Chen Qiyu (center), executive director and chairman of Fosun Pharma, poses for a photo with other VIPs at a press conference in Hong Kong on Tuesday. Provided to China Daily

Shanghai Fosun Pharmaceutical (Group) Co Ltd will launch an initial public offering on the Stock Exchange of Hong Kong on Tuesday, the biggest share sale in the last three months, to raise some HK$4.6 billion for business expansion.

The Shanghai-based drug producer plans to use 48 percent of its net proceeds from the IPO on acquisitions and consolidations in pharmaceutical related manufacturing, distribution and retail services; healthcare services and diagnostic products and medical devices.

"Mergers and acquisitions has always been an important element in the company's development plan," Chen Qiyu, executive director and chairman of the company, told a press conference in Hong Kong on Tuesday.

Chen said the company has a clear corporate strategy - to focus on pharmaceutical business development, especially in some specific therapeutic areas.

"We will keep looking for acquisitions targetsto improve our production lines as well as to increase our market share," said Chen.

Fosun Pharmaceutical also plans to spend 19 percent of its net proceeds on funding for existing research and development (R&D) projects, expansion of R&D team and acquisition of new R&D projects.

The company, which has been listed on the Shanghai Stock Exchange since 1998, is a subsidiary of Fosun International and it distributes products through spin-off Sinopharm Group.

Chen said that currently it holds a 32.1 percent stake in the Sinopharm Group and the strategic cooperation between them is very important to the company.

"Sinopharm Group owns a perfect pharmaceutical distribution network on the mainland, and it has a leading market share in over 20 provinces," he said, adding that the cooperation enables them to respond to tenders together and to manage inventories together.

Chen stressed that currently, Fosun Pharmaceutical has no plan to change its shareholding position in Sinopharm Group.

The company has secured two cornerstone investors, one is The Prudential Insurance Company of America and the other is International Finance Corporation, together they have agreed to subscribe for $75 million worth of shares from Fosun Pharma.

The company will open its retail book on Wednesday; the minimum entrance fee for 500 shares per board lot is HK$6,909. Its shares are expected to be listed on October 30.

The stock market in Hong Kong has been volatile due to the uncertainties of global economy. When asked if the company is worried about its share price on its debut, Chen said the company has confidence in its own business and it has faith in its future after it is listed in Hong Kong.

Joseph Chee, head of Global Capital Markets of Asia at UBS, said that the Hong Kong's stock market's performance is relatively good recently, and the price range of Fosun Pharmaceutical's H share offering is reasonable and has a discount compared with its A share price.

UBS AG, Hong Kong Branch is one of the Joint Sponsors of Fosun Pharma's IPO.

Fosun Pharma's A shares closed at 10.92 yuan (HK$13.5) in Shanghai on Tuesday.

sophiehe@chinadailyhk.com

 
8.03K
 
...
...
...
主站蜘蛛池模板: 国产高清精品自在线看 | 另类在线 | 色涩五月天 | 亚洲高清免费视频 | 日韩三级在线播放 | 久久久免费网站 | 久久视频在线观看免费 | 一区二区亚洲精品 | 国产精品久久久久激情影院 | 国产一国产一级毛片视频在线 | 国产呦精品系列在线 | 国产成人精品免费视频大全软件 | 日本在线亚州精品视频在线 | 欧美高清一区 | 波多野结衣福利视频 | xx欧美老妇 | 俄罗斯小屁孩cao大人免费 | 欧美白人最猛性xxxxx | 欧美一区二区在线观看 | fc2在线播放 | 日本精品久久久久久久 | 亚洲男人的天堂视频 | 特黄a三级三级三级 | 69视频在线观看xxxxx | 日韩精品在线观看免费 | 和老外3p爽粗大免费视频 | 成年午夜性爽快免费视频不卡 | 国内成人自拍视频 | 91av手机在线 | 免费午夜扒丝袜www在线看 | 国产精品99久久久久久宅男 | www中文字幕 | 成人区精品一区二区毛片不卡 | 在线另类| 中文字幕乱码中文乱码51精品 | 国产精品区牛牛影院 | 亚洲精品久久久久中文字幕一区 | 视频一区二区三区自拍 | 国产精品天天爽夜夜欢张柏芝 | 日本免费在线观看视频 | 国产成人免费高清在线观看 |